上咽頭がんの世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Nasopharyngeal Cancer Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-02121 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、上咽頭がんの世界市場を広く調査・分析し、今後の市場展望をまとめております。上咽頭がんの種類別市場規模（外科、放射線、化学療法）、用途別市場規模（病院、クリニック、がん治療・リハビリセンター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Cyclacel Pharmaceuticals、Sanofi、Merck、BioDiem、Celgene ・地域別グローバル市場分析 2015年-2020年 ・上咽頭がんの北米市場（アメリカ、カナダ、メキシコ） ・上咽頭がんのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・上咽頭がんのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・上咽頭がんの南米市場（ブラジル、アルゼンチン） ・上咽頭がんの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：外科、放射線、化学療法 ・用途別分析：病院、クリニック、がん治療・リハビリセンター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Nasopharyngeal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Nasopharyngeal Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Nasopharyngeal Cancer market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Nasopharyngeal Cancer market has been segmented into:
Surgery
Radiation
Chemotherapy

By Application, Nasopharyngeal Cancer has been segmented into:
Hospitals
Clinics
Cancer Treatment and Rehabilitation Centers

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nasopharyngeal Cancer market presented in the report. This section sheds light on the sales growth of different regional and country-level Nasopharyngeal Cancer markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nasopharyngeal Cancer market.

The report offers in-depth assessment of the growth and other aspects of the Nasopharyngeal Cancer market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Nasopharyngeal Cancer Market Share Analysis
Nasopharyngeal Cancer competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nasopharyngeal Cancer sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nasopharyngeal Cancer sales, revenue and market share for each player covered in this report.

The major players covered in Nasopharyngeal Cancer are:
Roche
Cyclacel Pharmaceuticals
Sanofi
Merck
BioDiem
Celgene

レポート目次

---

Table of Contents

1 Nasopharyngeal Cancer Market Overview
1.1 Product Overview and Scope of Nasopharyngeal Cancer
1.2 Classification of Nasopharyngeal Cancer by Type
1.2.1 Global Nasopharyngeal Cancer Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Nasopharyngeal Cancer Revenue Market Share by Type in 2019
1.2.3 Surgery
1.2.4 Radiation
1.2.5 Chemotherapy
1.3 Global Nasopharyngeal Cancer Market by Application
1.3.1 Overview: Global Nasopharyngeal Cancer Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Treatment and Rehabilitation Centers
1.4 Global Nasopharyngeal Cancer Market by Regions
1.4.1 Global Nasopharyngeal Cancer Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Nasopharyngeal Cancer (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Nasopharyngeal Cancer Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Nasopharyngeal Cancer Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nasopharyngeal Cancer Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Nasopharyngeal Cancer Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nasopharyngeal Cancer Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Nasopharyngeal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cyclacel Pharmaceuticals
2.2.1 Cyclacel Pharmaceuticals Details
2.2.2 Cyclacel Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cyclacel Pharmaceuticals SWOT Analysis
2.2.4 Cyclacel Pharmaceuticals Product and Services
2.2.5 Cyclacel Pharmaceuticals Nasopharyngeal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Nasopharyngeal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Nasopharyngeal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.5 BioDiem
2.5.1 BioDiem Details
2.5.2 BioDiem Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 BioDiem SWOT Analysis
2.5.4 BioDiem Product and Services
2.5.5 BioDiem Nasopharyngeal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.6 Celgene
2.6.1 Celgene Details
2.6.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Celgene SWOT Analysis
2.6.4 Celgene Product and Services
2.6.5 Celgene Nasopharyngeal Cancer Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Nasopharyngeal Cancer Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Nasopharyngeal Cancer Players Market Share
3.2.2 Top 10 Nasopharyngeal Cancer Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Nasopharyngeal Cancer Revenue and Market Share by Regions
4.2 North America Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
4.3 Europe Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
4.5 South America Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
5 North America Nasopharyngeal Cancer Revenue by Countries
5.1 North America Nasopharyngeal Cancer Revenue by Countries (2015-2020)
5.2 USA Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
5.3 Canada Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
5.4 Mexico Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
6 Europe Nasopharyngeal Cancer Revenue by Countries
6.1 Europe Nasopharyngeal Cancer Revenue by Countries (2015-2020)
6.2 Germany Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
6.3 UK Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
6.4 France Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
6.5 Russia Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
6.6 Italy Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nasopharyngeal Cancer Revenue by Countries
7.1 Asia-Pacific Nasopharyngeal Cancer Revenue by Countries (2015-2020)
7.2 China Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
7.3 Japan Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
7.4 Korea Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
7.5 India Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
8 South America Nasopharyngeal Cancer Revenue by Countries
8.1 South America Nasopharyngeal Cancer Revenue by Countries (2015-2020)
8.2 Brazil Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
8.3 Argentina Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nasopharyngeal Cancer by Countries
9.1 Middle East & Africa Nasopharyngeal Cancer Revenue by Countries (2015-2020)
9.2 Saudi Arabia Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
9.3 UAE Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
9.4 Egypt Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
9.5 South Africa Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Nasopharyngeal Cancer Revenue and Market Share by Type (2015-2020)
10.2 Global Nasopharyngeal Cancer Market Forecast by Type (2019-2024)
10.3 Surgery Revenue Growth Rate (2015-2025)
10.4 Radiation Revenue Growth Rate (2015-2025)
10.5 Chemotherapy Revenue Growth Rate (2015-2025)
11 Global Nasopharyngeal Cancer Market Segment by Application
11.1 Global Nasopharyngeal Cancer Revenue Market Share by Application (2015-2020)
11.2 Nasopharyngeal Cancer Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Cancer Treatment and Rehabilitation Centers Revenue Growth (2015-2020)
12 Global Nasopharyngeal Cancer Market Size Forecast (2021-2025)
12.1 Global Nasopharyngeal Cancer Market Size Forecast (2021-2025)
12.2 Global Nasopharyngeal Cancer Market Forecast by Regions (2021-2025)
12.3 North America Nasopharyngeal Cancer Revenue Market Forecast (2021-2025)
12.4 Europe Nasopharyngeal Cancer Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Nasopharyngeal Cancer Revenue Market Forecast (2021-2025)
12.6 South America Nasopharyngeal Cancer Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Nasopharyngeal Cancer Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Nasopharyngeal Cancer Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nasopharyngeal Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nasopharyngeal Cancer Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Nasopharyngeal Cancer Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Corporate Information, Location and Competitors
Table 6. Roche Nasopharyngeal Cancer Major Business
Table 7. Roche Nasopharyngeal Cancer Total Revenue (USD Million) (2017-2018)
Table 8. Roche SWOT Analysis
Table 9. Roche Nasopharyngeal Cancer Product and Solutions
Table 10. Roche Nasopharyngeal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Cyclacel Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Cyclacel Pharmaceuticals Nasopharyngeal Cancer Major Business
Table 13. Cyclacel Pharmaceuticals Nasopharyngeal Cancer Total Revenue (USD Million) (2018-2019)
Table 14. Cyclacel Pharmaceuticals SWOT Analysis
Table 15. Cyclacel Pharmaceuticals Nasopharyngeal Cancer Product and Solutions
Table 16. Cyclacel Pharmaceuticals Nasopharyngeal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sanofi Corporate Information, Location and Competitors
Table 18. Sanofi Nasopharyngeal Cancer Major Business
Table 19. Sanofi Nasopharyngeal Cancer Total Revenue (USD Million) (2017-2018)
Table 20. Sanofi SWOT Analysis
Table 21. Sanofi Nasopharyngeal Cancer Product and Solutions
Table 22. Sanofi Nasopharyngeal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Corporate Information, Location and Competitors
Table 24. Merck Nasopharyngeal Cancer Major Business
Table 25. Merck Nasopharyngeal Cancer Total Revenue (USD Million) (2017-2018)
Table 26. Merck SWOT Analysis
Table 27. Merck Nasopharyngeal Cancer Product and Solutions
Table 28. Merck Nasopharyngeal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. BioDiem Corporate Information, Location and Competitors
Table 30. BioDiem Nasopharyngeal Cancer Major Business
Table 31. BioDiem Nasopharyngeal Cancer Total Revenue (USD Million) (2017-2018)
Table 32. BioDiem SWOT Analysis
Table 33. BioDiem Nasopharyngeal Cancer Product and Solutions
Table 34. BioDiem Nasopharyngeal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Celgene Corporate Information, Location and Competitors
Table 36. Celgene Nasopharyngeal Cancer Major Business
Table 37. Celgene Nasopharyngeal Cancer Total Revenue (USD Million) (2017-2018)
Table 38. Celgene SWOT Analysis
Table 39. Celgene Nasopharyngeal Cancer Product and Solutions
Table 40. Celgene Nasopharyngeal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Nasopharyngeal Cancer Revenue (Million USD) by Players (2015-2020)
Table 42. Global Nasopharyngeal Cancer Revenue Share by Players (2015-2020)
Table 43. Global Nasopharyngeal Cancer Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Nasopharyngeal Cancer Revenue Market Share by Regions (2015-2020)
Table 45. North America Nasopharyngeal Cancer Revenue by Countries (2015-2020)
Table 46. North America Nasopharyngeal Cancer Revenue Market Share by Countries (2015-2020)
Table 47. Europe Nasopharyngeal Cancer Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Nasopharyngeal Cancer Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Nasopharyngeal Cancer Revenue by Countries (2015-2020)
Table 50. South America Nasopharyngeal Cancer Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Nasopharyngeal Cancer Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Nasopharyngeal Cancer Revenue Market Share by Countries (2015-2020)
Table 53. Global Nasopharyngeal Cancer Revenue (Million USD) by Type (2015-2020)
Table 54. Global Nasopharyngeal Cancer Revenue Share by Type (2015-2020)
Table 55. Global Nasopharyngeal Cancer Revenue Forecast by Type (2021-2025)
Table 56. Global Nasopharyngeal Cancer Revenue by Application (2015-2020)
Table 57. Global Nasopharyngeal Cancer Revenue Share by Application (2015-2020)
Table 58. Global Nasopharyngeal Cancer Revenue Forecast by Application (2021-2025)
Table 59. Global Nasopharyngeal Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Nasopharyngeal Cancer Picture
Figure 2. Global Nasopharyngeal Cancer Revenue Market Share by Type in 2019
Figure 3. Surgery Picture
Figure 4. Radiation Picture
Figure 5. Chemotherapy Picture
Figure 6. Nasopharyngeal Cancer Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Cancer Treatment and Rehabilitation Centers Picture
Figure 10. Global Nasopharyngeal Cancer Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Nasopharyngeal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Nasopharyngeal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Nasopharyngeal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Nasopharyngeal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Nasopharyngeal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Nasopharyngeal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Nasopharyngeal Cancer Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Nasopharyngeal Cancer Revenue Market Share in 2019
Figure 19. Global Top 10 Players Nasopharyngeal Cancer Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Nasopharyngeal Cancer Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Nasopharyngeal Cancer Revenue Market Share by Regions (2015-2020)
Figure 23. Global Nasopharyngeal Cancer Revenue Market Share by Regions in 2018
Figure 24. North America Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 25. Europe Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 27. South America Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 29. North America Nasopharyngeal Cancer Revenue Market Share by Countries (2015-2020)
Figure 30. North America Nasopharyngeal Cancer Revenue Market Share by Countries in 2019
Figure 31. USA Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 32. Canada Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 34. Europe Nasopharyngeal Cancer Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Nasopharyngeal Cancer Revenue Market Share by Countries in 2019
Figure 36. Germany Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 37. UK Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 38. France Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 39. Russia Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 40. Italy Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Nasopharyngeal Cancer Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Nasopharyngeal Cancer Revenue Market Share by Countries in 2019
Figure 43. China Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 44. Japan Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 45. Korea Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 46. India Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 48. South America Nasopharyngeal Cancer Revenue Market Share by Countries (2015-2020)
Figure 49. South America Nasopharyngeal Cancer Revenue Market Share by Countries in 2019
Figure 50. Brazil Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Nasopharyngeal Cancer Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Nasopharyngeal Cancer Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 55. UAE Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Nasopharyngeal Cancer Revenue and Growth Rate (2015-2020)
Figure 58. Global Nasopharyngeal Cancer Revenue Share by Type (2015-2020)
Figure 59. Global Nasopharyngeal Cancer Revenue Share by Type in 2019
Figure 60. Global Nasopharyngeal Cancer Market Share Forecast by Type (2021-2025)
Figure 61. Global Surgery Revenue Growth Rate (2015-2020)
Figure 62. Global Radiation Revenue Growth Rate (2015-2020)
Figure 63. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 64. Global Nasopharyngeal Cancer Revenue Share by Application (2015-2020)
Figure 65. Global Nasopharyngeal Cancer Revenue Share by Application in 2019
Figure 66. Global Nasopharyngeal Cancer Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Cancer Treatment and Rehabilitation Centers Revenue Growth Rate (2015-2020)
Figure 70. Global Nasopharyngeal Cancer Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Nasopharyngeal Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Nasopharyngeal Cancer Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Nasopharyngeal Cancer Revenue Market Forecast (2021-2025)
Figure 74. Europe Nasopharyngeal Cancer Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Nasopharyngeal Cancer Revenue Market Forecast (2021-2025)
Figure 76. South America Nasopharyngeal Cancer Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Nasopharyngeal Cancer Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

---